Want to see IL:SOFW full AI Analyst Report?
Top Page
Sofwave
(TASE:SOFW)
Select Model
Select Model
Rating:65Neutral
Price Target:
4,174.00
▲(8.42% Upside)
Action:Downgraded
Date:08/07/26
The score is supported primarily by improved fundamentals (return to positive margins and free cash flow) and a very conservatively levered balance sheet. Offsetting this, technical indicators point to a current downtrend, and valuation is stretched (P/E ~58) without dividend support.
Positive Factors
High gross margins and return to profitability
TTM gross margin near 75% and recent positive operating and net margins indicate durable unit economics and pricing power in a device-plus-consumable model. Strong gross margins support reinvestment in training, service and go-to-market, helping sustain profits through growth phases.
Negative Factors
Prior multi-year losses and cash-burn history
Historical multi-year losses and past cash burn create execution risk: if growth slows or utilization dips the company could revert to negative margins. Management must sustain margin discipline and stable cash conversion to avoid recurrence of prior loss periods.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross margins and return to profitability
TTM gross margin near 75% and recent positive operating and net margins indicate durable unit economics and pricing power in a device-plus-consumable model. Strong gross margins support reinvestment in training, service and go-to-market, helping sustain profits through growth phases.
Read all positive factors
Sofwave (SOFW) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪1.32B
Dividend YieldN/A
Average Volume (3M)26.78K
Price to Earnings (P/E)48.2
Beta (1Y)0.72
Revenue Growth30.12%
EPS GrowthN/A
CountryIL
Employees151
SectorGeneral
Sector StrengthN/A
IndustryMedical - Devices
Share Statistics
EPS (TTM)N/A
Shares Outstanding36,348,373
10 Day Avg. Volume28,238
30 Day Avg. Volume26,779
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)9.34
Price to Sales (P/S)3.22
P/FCF Ratio21.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Sofwave Business Overview & Revenue Model
Company Description
Founded in 2015, Sofwave Medical Ltd. is an Israeli company dedicated to developing cutting-edge ultrasound technology. This technology is employed for the non-invasive treatment of fine lines and wrinkles, with the company's reach extending to ph...
How the Company Makes Money
Sofwave primarily makes money by selling its energy-based aesthetic device platform and related consumables/services to medical practices and other clinical customers. Key revenue streams typically include: (1) capital equipment sales (one-time sa...
Sofwave Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
88
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 104.85M | 94.86M | 59.65M | 50.31M | 35.63M | 21.84M |
| Gross Profit | 78.97M | 70.27M | 45.34M | 37.48M | 26.33M | 16.24M |
| EBITDA | 12.28M | 9.39M | -2.19M | -6.61M | -17.55M | -6.43M |
| Net Income | 8.92M | 5.94M | -4.55M | -8.28M | -19.53M | -6.83M |
Balance Sheet | ||||||
| Total Assets | 61.72M | 55.78M | 43.03M | 43.54M | 46.08M | 60.77M |
| Cash, Cash Equivalents and Short-Term Investments | 38.57M | 35.28M | 21.62M | 24.42M | 32.01M | 46.22M |
| Total Debt | 1.42M | 1.12M | 1.40M | 1.33M | 1.92M | 2.37M |
| Total Liabilities | 23.95M | 23.06M | 18.50M | 17.19M | 13.74M | 14.07M |
| Stockholders Equity | 37.77M | 32.72M | 24.53M | 26.34M | 32.34M | 46.70M |
Cash Flow | ||||||
| Free Cash Flow | 14.81M | 14.51M | -2.67M | -6.71M | -11.14M | -2.92M |
| Operating Cash Flow | 15.61M | 15.08M | -2.40M | -6.31M | -10.69M | -2.10M |
| Investing Cash Flow | -10.98M | -1.15M | 254.00K | 409.00K | -260.00K | -982.00K |
| Financing Cash Flow | 20.23K | -469.79K | -620.00K | -1.72M | -1.35M | 46.64M |
Sofwave Technical Analysis
Negative
3850.00
Price Trends
4126.78
Negative
4153.30
Negative
3672.26
Negative
Market Momentum
-129.94
Positive
31.95
Neutral
15.20
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:SOFW, the sentiment is Negative. The current price of 3850 is below the 20-day moving average (MA) of 4062.65, below the 50-day MA of 4126.78, and above the 200-day MA of 3672.26, indicating a bearish trend. The MACD of -129.94 indicates Positive momentum. The RSI at 31.95 is Neutral, neither overbought nor oversold. The STOCH value of 15.20 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:SOFW.
Sofwave Peers Comparison
UnderperformOutperform
Sector (55)
IL:SOFW
Sofwave
3,611.00
765.00
26.88%
IL:BWAY
Brainsway
4,700.00
2,480.00
111.71%
IL:ILX
Ilex Medical
5,172.00
-642.64
-11.05%
IL:ALMD
Allmed Solution
29.40
-2.70
-8.41%
IL:EPIT
Epitomee Med
362.70
-531.90
-59.46%
IL:PLSM
Pulsenmore
883.00
-1,625.48
-64.80%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.